Regeneron suspended testing its antibody cocktail in patients on high-flow oxygen or ventilation after an independent data monitoring committee flagged safety concerns. Two other cohorts in the trial—which focuses on hospitalized patients—are continuing as planned, and a separate trial in outpatients will also continue.
The CDC asked states to come up with vaccine distribution plans by Tuesday as WHO announced it's not convinced the front-runner shots actually work in the elderly.
Plus, smartwatches and Fitbits could help spot COVID-19 cases and support public health efforts to slow the disease's spread, a new study found.
This is your answer and please mark me as a Brainlist
Answers & Comments
Regeneron suspended testing its antibody cocktail in patients on high-flow oxygen or ventilation after an independent data monitoring committee flagged safety concerns. Two other cohorts in the trial—which focuses on hospitalized patients—are continuing as planned, and a separate trial in outpatients will also continue.
The CDC asked states to come up with vaccine distribution plans by Tuesday as WHO announced it's not convinced the front-runner shots actually work in the elderly.
Plus, smartwatches and Fitbits could help spot COVID-19 cases and support public health efforts to slow the disease's spread, a new study found.
This is your answer and please mark me as a Brainlist